Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Photodermatol Photoimmunol Photomed. 2022 Mar;38(2):141-149. doi: 10.1111/phpp.12727. Epub 2021 Aug 30.
Erythropoietic protoporphyria (EPP) is a rare disorder of heme biosynthesis hallmarked by early-onset photosensitivity and mainly due to defective ferrochelatase activity leading to increased erythrocyte protoporphyrin IX (PPIX) levels. Evidence regarding the relationship between erythrocyte PPIX concentration and photosensitivity is limited.
To investigate the relationship between free erythrocyte PPIX (FEP) concentration; routine laboratory tests, particularly iron metabolism biomarkers; and ultraviolet (UV) A/visible light phototesting findings, 20 genetically confirmed EPP and one XLPP treatment-naive patients were included in our study. They underwent UVA and visible light phototesting. On the same day, blood samples were collected for measurement of FEP, serum iron, transferrin, transferrin saturation, and ferritin, 25-hydroxyvitamin D, and liver enzyme levels.
Median FEP concentration at the time of phototesting was 57.50 (IQR: 34.58-102.70) μg/g of Hb. UVA and visible light phototesting were positive in 9 (42.9%) and 8 (38.1%) patients, respectively. Median FEP concentration was significantly higher in UVA phototest-positive patients than in those negative (64.37 [IQR: 57.45-121.82] vs 45.35 [IQR: 24.53-74.61] μg/g of Hb, respectively; P = .04486). Similarly, UVA photosensitive individuals had significantly lower median serum iron levels (61.5 [IQR: 33.5-84] μg/dL vs 109 [IQR: 63.25-154] μg/dL, respectively; P = .01862) and transferrin saturation values (15.005 [IQR: 7.0775-18.41] % vs 29.645 [IQR: 17.8225-34.3575] %; P = .0109) than those negative.
Our study demonstrates that UVA phototest positivity is associated with higher FEP concentration and lower transferrin saturation and serum iron concentration in EPP.
红细胞生成性原卟啉症(EPP)是一种罕见的血红素生物合成疾病,其特征为早发性光敏感性,主要由于亚铁螯合酶活性缺陷导致红细胞原卟啉 IX(PPIX)水平升高。关于红细胞 PPIX 浓度与光敏感性之间的关系的证据有限。
为了研究游离红细胞 PPIX(FEP)浓度与光敏感之间的关系;常规实验室检查,特别是铁代谢生物标志物;以及紫外线(UVA)/可见光光试验结果,我们纳入了 20 名基因确诊的 EPP 患者和 1 名 XLPP 初治患者进行研究。他们接受了 UVA 和可见光光试验。在同一天,采集血液样本测量 FEP、血清铁、转铁蛋白、转铁蛋白饱和度和铁蛋白、25-羟维生素 D 和肝酶水平。
光试验时的中位 FEP 浓度为 57.50(IQR:34.58-102.70)μg/gHb。UVA 和可见光光试验阳性的患者分别为 9 名(42.9%)和 8 名(38.1%)。UVA 光试验阳性患者的 FEP 浓度中位数明显高于阴性患者(64.37 [IQR:57.45-121.82] vs 45.35 [IQR:24.53-74.61]μg/gHb,分别;P=.04486)。同样,UVA 光敏个体的血清铁水平中位数明显较低(61.5 [IQR:33.5-84]μg/dL vs 109 [IQR:63.25-154]μg/dL,分别;P=.01862)和转铁蛋白饱和度值(15.005 [IQR:7.0775-18.41]% vs 29.645 [IQR:17.8225-34.3575]%,分别;P=.0109)低于阴性患者。
我们的研究表明,EPP 中 UVA 光试验阳性与 FEP 浓度升高、转铁蛋白饱和度和血清铁浓度降低有关。